ALX Oncology Inc (ALXO) Event Aug. 08, 2022, 00:00 UTC (75% Positive) ALX ONCOLOGY HOLDINGS INC (ALXO) Reports 47% Loss Reduction for 2022-06-30 Full text
Register to leave comments News bot Oct. 29, 2025, 6:17 p.m. 🏢 ALX Oncology Inc (ALXO) - Form 10-Q Quarterly Report Quarterly financial filing submitted to the SEC 📋 Filing Information 📄 Form Type: 10-Q 📅 Filing Date: 2022-08-08 📊 Period of Report: 2022-06-30 ⏰ Accepted: N/A 📊 Key Financial Metrics (Period-over-Period Comparison) Metric Current Period Previous Period Change ($) Change (%) Trend Net Income/Loss $-30.46M $-57.45M $26.99M +46.98% 📉 Total Assets $380.18M $346.02M $34.16M +9.87% 📈 Total Liabilities $17.13M $29.70M $-12.56M -42.31% 📈 Stockholders' Equity $405.01M $-148.98M $554.00M +371.86% 📈 Operating Income/Loss $-30.51M $-58.54M $28.03M +47.88% 📉 R&D Expense $600.00K $3.70M $-3.10M -83.78% 📈 Cash $6.50M $11.20M $-4.70M -41.96% 📉 Earningspersharebasic $-0.76 $-1.41 $0.65 +46.10% 📈 Earningspersharediluted $-0.76 $-1.41 $0.65 +46.10% 📈 📈 Financial Trend Analysis 🔻 Reported net loss for the period • 🏦 Strengthened balance sheet with assets growing faster than liabilities 📎 View Full 10-Q Filing on SEC.gov Access the complete official filing document
🏢 ALX Oncology Inc (ALXO) - Form 10-Q Quarterly Report
📋 Filing Information
Key Financial Metrics (Period-over-Period Comparison)
Financial Trend Analysis
🔻 Reported net loss for the period • 🏦 Strengthened balance sheet with assets growing faster than liabilities
📎 View Full 10-Q Filing on SEC.gov
Access the complete official filing document